Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium

PURPOSE: In 75% of ovarian cancer patients the tumor mass is completely eradicated by established surgical and cytotoxic treatment; however, the majority of the tumors recur within 24 months. Here we investigated the role of circulating tumor cells (CTCs) indicating occult tumor load, which remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Obermayr, Eva, Bednarz-Knoll, Natalia, Orsetti, Beatrice, Weier, Heinz-Ulrich, Lambrechts, Sandrina, Castillo-Tong, Dan Cacsire, Reinthaller, Alexander, Braicu, Elena Ioana, Mahner, Sven, Sehouli, Jalid, Vergote, Ignace, Theillet, Charles, Zeillinger, Robert, Brandt, Burkhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739744/
https://www.ncbi.nlm.nih.gov/pubmed/29290959
http://dx.doi.org/10.18632/oncotarget.22468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739744/
https://www.ncbi.nlm.nih.gov/pubmed/29290959
http://dx.doi.org/10.18632/oncotarget.22468

Ejemplares similares